The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
Abstract
Left ventricular hypertrophy (LVH) is the major risk factor associated with myocardial failure. An explanation for why a presumptive adaptation such as LVH would prove pathological has been elusive. Insights into the impairment in contractility of the hypertrophied myocardium have been sought in the biochemistry of cardiac myocyte contraction. Equally compelling is a consideration of abnormalities in myocardial structure that impair organ contractile function while preserving myocyte contractility. For example, in the LVH that accompanies hypertension, the extracellular space is frequently the site of an abnormal accumulation of fibrillar collagen. This reactive and progressive interstitial and perivascular fibrosis accounts for abnormal myocardial stiffness and ultimately ventricular dysfunction and is likely a result of cardiac fibroblast growth and enhanced collagen synthesis. The disproportionate involvement of this nonmyocyte cell, however, is not a uniform accompaniment to myocyte hypertrophy and LVH, suggesting that the growth of myocyte and nonmyocyte cells is independent of each other. This has now been demonstrated in in vivo studies of experimental hypertension in which the abnormal fibrous tissue response was found in the hypertensive, hypertrophied left ventricle as well as in the normotensive, nonhypertrophied right ventricle. These findings further suggest that a circulating substance that gained access to the common coronary circulation of the ventricles was involved. This hypothesis has been tested in various animal models in which plasma concentrations of angiotensin II and aldosterone were varied. Based on morphometric and morphological findings, it can be concluded that arterial hypertension (i.e., an elevation in coronary perfusion pressure) together with elevated circulating aldosterone are associated with cardiac fibroblast involvement and the resultant heterogeneity in tissue structure. Nonmyocyte cells of the cardiac interstitium represent an important determinant of pathological LVH. The mechanisms that invoke short- (e.g., collagen metabolism) and long-term (e.g., mitosis) responses of cardiac fibroblasts require further investigation and integration of in vitro with in vivo studies. The stage is set, however, to prevent pathological LVH resulting from myocardial fibrosis as well as to reverse it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
INOSITOL TRISPHOSPHATE AND DIACYLGLYCEROL: TWO INTERACTING SECOND MESSENGERS
Berridge, M. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001111 · Cited by 3,285
Junqueira, L. C. U., Bignolas, G., & Brentani, R. R. (1979) · The Histochemical Journal · doi:10.1007/bf01002772 · Cited by 2,574
Early Signals in the Mitogenic Response
Rozengurt, E. (1986) · Science · doi:10.1126/science.3018928 · Cited by 1,455
Cardiac interstitium in health and disease: The fibrillar collagen network
Weber, K. T. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90360-4 · Cited by 1,056
Self-citationEndothelium and control of vascular function. State of the Art lecture.
Vanhoutte, P. M. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.658 · Cited by 669
Role of phosphoinositides in transmembrane signaling.
Rana, R. S., & Hokin, L. E. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.1.115 · Cited by 482
(1979) · PubMed · Cited by 470
Stretching cardiac myocytes stimulates protooncogene expression.
Komuro, I., Kaida, T., Shibazaki, Y., Kurabayashi, M., Katoh, Y., Hoh, E., Takaku, F., & Yazaki, Y. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39631-0 · Cited by 460
Laurent, G. J. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.252.1.c1 · Cited by 385
Brilla, C. G., Janicki, J. S., & Weber, K. T. (1991) · Circulation · doi:10.1161/01.cir.83.5.1771 · Cited by 325
Self-citation
Cited by
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Messroghli, D. R., Moon, J. C., Ferreira, V. M., Grosse-Wortmann, L., He, T., Kellman, P., Mascherbauer, J., Nezafat, R., Salerno, M., Schelbert, E. B., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0389-8 · Cited by 1,727
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Promotion of Atrial Fibrillation by Heart Failure in Dogs: Atrial Remodeling of a Different Sort
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,341
Left Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,184
Moon, J. C., Messroghli, D. R., Kellman, P., Piechnik, S. K., Robson, M. D., Ugander, M., Gatehouse, P. D., Arai, A. E., Friedrich, M. G., Neubauer, S., et al. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-92 · Cited by 1,136
Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance
Mewton, N., Liu, C. Y., Croisille, P., Bluemke, D., & Lima, J. A. C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.013 · Cited by 984
Structural and functional characterisation of cardiac fibroblasts
CAMELLITI, P., BORG, T., & KOHL, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.020 · Cited by 930
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1202.105290 · Cited by 887
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Apoptosis: Basic Mechanisms and Implications for Cardiovascular Disease
Haunstetter, A., & Izumo, S. (1998) · Circulation Research · doi:10.1161/01.res.82.11.1111 · Cited by 807
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Kakkar, R., & Lee, R. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2660 · Cited by 794
Frohlich, E. D., Apstein, C., Chobanian, A. V., Devereux, R. B., Dustan, H. P., Dzau, V., Fauad-Tarazi, F., Horan, M. J., Marcus, M., Massie, B., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210013271406 · Cited by 782
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Self-citationAurigemma, G. P., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp022709 · Cited by 764
Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., Campbell, W. B., Haines, D. E., Kuck, K. H., Lerman, B. B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.013 · Cited by 689
TGF-?1 and angiotensin networking in cardiac remodeling
ROSENKRANZ, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.030 · Cited by 683
Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease
Brilla, C. G., Funck, R. C., & Rupp, H. (2000) · Circulation · doi:10.1161/01.cir.102.12.1388 · Cited by 649
Self-citationSteroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, R., Kolkhof, P., Bakris, G., Bauersachs, J., Haller, H., Wada, T., & Zannad, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa736 · Cited by 638
Pitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., & Williams, G. H. (2003) · Circulation · doi:10.1161/01.cir.0000091405.00772.6e · Cited by 623
Cardiac fibrosis in mice lacking brain natriuretic peptide
Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M., Kasahara, M., Hashimoto, R., Katsuura, G., Mukoyama, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070371497 · Cited by 620
How to diagnose diastolic heart failure
European Study Group on Diastolic H (1998) · European Heart Journal · doi:10.1053/euhj.1998.1057 · Cited by 615
Goette, A., Staack, T., Röcken, C., Arndt, M., Geller, J. C., Huth, C., Ansorge, S., Klein, H. U., & Lendeckel, U. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00611-2 · Cited by 583
Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F. D., Dal Bello, B., Semigran, M. J., Bielsa-Masdeu, A., Dec, G. W., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8144 · Cited by 585
Marwick, T. H., Gillebert, T. C., Aurigemma, G., Chirinos, J., Derumeaux, G., Galderisi, M., Gottdiener, J., Haluska, B., Ofili, E., Segers, P., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.05.002 · Cited by 583
Cardiac Fibroblasts Regulate Myocardial Proliferation through β1 Integrin Signaling
Ieda, M., Tsuchihashi, T., Ivey, K. N., Ross, R. S., Hong, T.-T., Shaw, R. M., & Srivastava, D. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.007 · Cited by 580
Extracellular Matrix Remodeling in Heart Failure: A Role for De Novo Angiotensin II Generation
Weber, K. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.4065 · Cited by 557
Self-citationPathophysiology of Heart Failure
Tanai, E., & Frantz, S. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140055 · Cited by 552
SACCÀ, L., CITTADINI, A., & FAZIO, S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-555 · Cited by 543
Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
Adams, J. W., Sakata, Y., Davis, M. G., Sah, V. P., Wang, Y., Liggett, S. B., Chien, K. R., Brown, J. H., & Dorn, G. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10140 · Cited by 525
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E. M., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 503
(1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00465-1 · Cited by 494
Wong, T. C., Piehler, K., Meier, C. G., Testa, S. M., Klock, A. M., Aneizi, A. A., Shakesprere, J., Kellman, P., Shroff, S. G., Schwartzman, D. S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.089409 · Cited by 493
Myocardial fibrosis: functional significance and regulatory factors
Weber, K. T., Brilla, C. G., & Janicki, J. S. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.3.341 · Cited by 480
Self-citationPathophysiology of chronic heart failure
Packer, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90405-r · Cited by 473
Eichhorn, E. J., & Bristow, M. R. (1996) · Circulation · doi:10.1161/01.cir.94.9.2285 · Cited by 468
Induction of Cardiac Fibrosis by Transforming Growth Factor-β1
Lijnen, P. J., Petrov, V. V., & Fagard, R. H. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3032 · Cited by 464
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457
Ross, R. S., & Borg, T. K. (2001) · Circulation Research · doi:10.1161/hh1101.091862 · Cited by 451
Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, A. J., & Spinale, F. G. (1998) · Circulation · doi:10.1161/01.cir.97.17.1708 · Cited by 443
Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M., & Inada, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117675 · Cited by 435
Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation
Gibb, A. A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 434
The renin-angiotensin-aldosterone system and its suppression
Ames, M. K., Atkins, C. E., & Pitt, B. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15454 · Cited by 433
Cardiac fibroblasts: friend or foe?
Baudino, T. A., Carver, W., Giles, W., & Borg, T. K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00023.2006 · Cited by 427
Levin, H. R., Oz, M. C., Chen, J. M., Packer, M., Rose, E. A., & Burkhoff, D. (1995) · Circulation · doi:10.1161/01.cir.91.11.2717 · Cited by 423
Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure
Eshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.072 · Cited by 410
Shirani, J., Pick, R., Roberts, W. C., & Maron, B. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00492-1 · Cited by 408
Bell, D. S. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2433 · Cited by 404
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.
Schorb, W., Booz, G. W., Dostal, D. E., Conrad, K. M., Chang, K. C., & Baker, K. M. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1245 · Cited by 391
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
Weinberger, M. H., Roniker, B., Krause, S. L., & Weiss, R. J. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02957-6 · Cited by 388
MacKenna, D. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00030-4 · Cited by 387
Miller, C. A., Naish, J. H., Bishop, P., Coutts, G., Clark, D., Zhao, S., Ray, S. G., Yonan, N., Williams, S. G., Flett, A. S., et al. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.000192 · Cited by 384
Wong, T. C., Piehler, K. M., Kang, I. A., Kadakkal, A., Kellman, P., Schwartzman, D. S., Mulukutla, S. R., Simon, M. A., Shroff, S. G., Kuller, L. H., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht193 · Cited by 379
Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human Heart
Li, Y. Y., Feldman, A. M., Sun, Y., & McTiernan, C. F. (1998) · Circulation · doi:10.1161/01.cir.98.17.1728 · Cited by 372
Segura, A. M., Frazier, O. H., & Buja, L. M. (2014) · Heart Failure Reviews · doi:10.1007/s10741-012-9365-4 · Cited by 371
Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status
Ma, T. K., Kam, K. K., Yan, B. P., & Lam, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00750.x · Cited by 364
Falcão-Pires, I., & Leite-Moreira, A. F. (2012) · Heart Failure Reviews · doi:10.1007/s10741-011-9257-z · Cited by 363
Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01116-0 · Cited by 363
Senni, M., Paulus, W. J., Gavazzi, A., Fraser, A. G., Diez, J., Solomon, S. D., Smiseth, O. A., Guazzi, M., Lam, C. S. P., Maggioni, A. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu204 · Cited by 355
Diastolic Dysfunction in Congestive Heart Failure
Flier, J. S., Underhill, L. H., & Grossman, W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111283252206 · Cited by 353
Dass, S., Suttie, J. J., Piechnik, S. K., Ferreira, V. M., Holloway, C. J., Banerjee, R., Mahmod, M., Cochlin, L., Karamitsos, T. D., Robson, M. D., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.976738 · Cited by 348
Aldosterone Production Is Activated in Failing Ventricle in Humans
Mizuno, Y., Yoshimura, M., Yasue, H., Sakamoto, T., Ogawa, H., Kugiyama, K., Harada, E., Nakayama, M., Nakamura, S., Ito, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.72 · Cited by 345
Domanski, M., Norman, J., Pitt, B., Haigney, M., Hanlon, S., & Peyster, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00765-4 · Cited by 337
Heart Failure Society Of America (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)91340-4 · Cited by 336
London, G. M., Pannier, B., Guerin, A. P., Marchais, S. J., Safar, M. E., & Cuche, J. L. (1994) · Circulation · doi:10.1161/01.cir.90.6.2786 · Cited by 336
Cardiac fibrosis: new insights into the pathogenesis
Ma, Z.-G., Yuan, Y.-P., Wu, H.-M., Zhang, X., & Tang, Q.-Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.28103 · Cited by 331
Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism
Rossi, G. P., Sacchetto, A., Visentin, P., Canali, C., Graniero, G. R., Palatini, P., & Pessina, A. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1039 · Cited by 328
Diastolic failure: Pathophysiology and therapeutic implications
Brutsaert, D. L., Sys, S. U., & Gillebert, T. C. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90850-z · Cited by 326
Ruskoaho, H., Leskinen, H., Magga, J., Taskinen, P., Mäntymaa, P., Vuolteenaho, O., & Leppäluoto, J. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050179 · Cited by 324
Molecular and Cellular Mechanisms of Myocardial Failure
Colucci, W. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00845-x · Cited by 322
Hayashi, M., Tsutamoto, T., Wada, A., Tsutsui, T., Ishii, C., Ohno, K., Fujii, M., Taniguchi, A., Hamatani, T., Nozato, Y., et al. (2003) · Circulation · doi:10.1161/01.cir.0000068340.96506.0f · Cited by 319
Remodeling and reparation of the cardiovascular system
Weber, K. T., Anversa, P., Armstrong, P. W., Brilla, C. G., Burnett, J. C., Cruickshank, J. M., Devereux, R. B., Giles, T. D., Korsgaard, N., Leier, C. V., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90130-f · Cited by 312
Self-citationLitwin, S. E., Katz, S. E., Weinberg, E. O., Lorell, B. H., Aurigemma, G. P., & Douglas, P. S. (1995) · Circulation · doi:10.1161/01.cir.91.10.2642 · Cited by 309
The fibrosis-cell death axis in heart failure
Piek, A., de Boer, R. A., & Silljé, H. H. W. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9536-9 · Cited by 301
Fibrosis and hypertensive heart disease
Weber, K. T. (2000) · Current Opinion in Cardiology · doi:10.1097/00001573-200007000-00010 · Cited by 300
Self-citationLeft Ventricular Diastolic Dysfunction and Diastolic Heart Failure
Gaasch, W. H., & Zile, M. R. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104417 · Cited by 299
Ichihara, S., Senbonmatsu, T., Price, E., Ichiki, T., Gaffney, F. A., & Inagami, T. (2001) · Circulation · doi:10.1161/01.cir.104.3.346 · Cited by 299
White, W. B., Duprez, D., St Hillaire, R., Krause, S., Roniker, B., Kuse-Hamilton, J., & Weber, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000067463.13172.ea · Cited by 295
Myocyte Death in Streptozotocin-Induced Diabetes in Rats Is Angiotensin II- Dependent
Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E. H., Anversa, P., Leri, A., & Kajstura, J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780057 · Cited by 292
Hunter, P. J., Pullan, A. J., & Smaill, B. H. (2003) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.5.040202.121537 · Cited by 291
Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction
Verma, A., Meris, A., Skali, H., Ghali, J. K., Arnold, J. M. O., Bourgoun, M., Velazquez, E. J., McMurray, J. J. V., Kober, L., Pfeffer, M. A., et al. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.05.012 · Cited by 288
Pozzi, M., Carugo, S., Boari, G., Pecci, V, de Ceglia, S., Maggiolini, S., Bolla, G. B., Roffi, L., Failla, M., Grassi, G., et al. (1997) · Hepatology · doi:10.1002/hep.510260507 · Cited by 287
Edwards, N. C., Steeds, R. P., Stewart, P. M., Ferro, C. J., & Townend, J. N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.066 · Cited by 286
Rossi, M. A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00018 · Cited by 285
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
Kim, H. E., Dalal, S. S., Young, E., Legato, M. J., Weisfeldt, M. L., & D’Armiento, J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8040 · Cited by 281
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90239-9 · Cited by 278
Self-citationMottram, P. M., Haluska, B., Leano, R., Cowley, D., Stowasser, M., & Marwick, T. H. (2004) · Circulation · doi:10.1161/01.cir.0000138680.89536.a9 · Cited by 278
Iles, L. M., Ellims, A. H., Llewellyn, H., Hare, J. L., Kaye, D. M., McLean, C. A., & Taylor, A. J. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu182 · Cited by 278
Quiñones, M. A., Greenberg, B. H., Kopelen, H. A., Koilpillai, C., Limacher, M. C., Shindler, D. M., Shelton, B. J., & Weiner, D. H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00511-8 · Cited by 276
Remodeling of the Left Ventricle in Primary Aldosteronism Due to Conn’s Adenoma
Rossi, G. P., Sacchetto, A., Pavan, E., Palatini, P., Graniero, G. R., Canali, C., & Pessina, A. C. (1997) · Circulation · doi:10.1161/01.cir.95.6.1471 · Cited by 273
Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis
Bing, R., Cavalcante, J. L., Everett, R. J., Clavel, M.-A., Newby, D. E., & Dweck, M. R. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.11.026 · Cited by 273
Stowasser, M., Sharman, J., Leano, R., Gordon, R. D., Ward, G., Cowley, D., & Marwick, T. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0681 · Cited by 271
The cellular basis of dilated cardiomyopathy in humans
BELTRAMI, C., FINATO, N., ROCCO, M., FERUGLIO, G., PURICELLI, C., CIGOLA, E., SONNENBLICK, E., OLIVETTI, G., & ANVERSA, P. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80028-4 · Cited by 270
Izawa, H., Murohara, T., Nagata, K., Isobe, S., Asano, H., Amano, T., Ichihara, S., Kato, T., Ohshima, S., Murase, Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.571653 · Cited by 268
The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventions
Cleutjens, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00212-6 · Cited by 268
Metadata
- Authors
- Weber, K. T., & Brilla, C. G.
- Venue
- Circulation
- Published
- 1991-06
- Volume
- 83
- Issue
- 6
- Pages
- 1849-1865
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1977152294
- Cited by
- 2,027
- References
- 46
- FWCI
- 41.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.